mesalamine has been researched along with Local Neoplasm Recurrence in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Louis, E | 1 |
Paridaens, K | 1 |
Al Awadhi, S | 1 |
Begun, J | 1 |
Cheon, JH | 1 |
Dignass, AU | 1 |
Magro, F | 1 |
Márquez, JR | 1 |
Moschen, AR | 1 |
Narula, N | 1 |
Rydzewska, G | 1 |
Freddi, MJ | 1 |
Travis, SP | 1 |
Ishikawa, H | 1 |
Mutoh, M | 1 |
Sato, Y | 1 |
Doyama, H | 1 |
Tajika, M | 1 |
Tanaka, S | 1 |
Horimatsu, T | 1 |
Takeuchi, Y | 1 |
Kashida, H | 1 |
Tashiro, J | 1 |
Ezoe, Y | 1 |
Nakajima, T | 1 |
Ikematsu, H | 1 |
Hori, S | 1 |
Suzuki, S | 1 |
Otani, T | 1 |
Takayama, T | 1 |
Ohda, Y | 1 |
Mure, K | 1 |
Wakabayashi, K | 1 |
Sakai, T | 1 |
Papaioannou, D | 1 |
Rafia, R | 1 |
Stevenson, MD | 1 |
Stevens, JW | 1 |
Evans, P | 1 |
1 review available for mesalamine and Local Neoplasm Recurrence
Article | Year |
---|---|
Trabectedin for the treatment of relapsed ovarian cancer.
Topics: Antineoplastic Agents, Alkylating; Dioxoles; Doxorubicin; Female; Humans; Mesalamine; Meta-Analysis | 2011 |
1 trial available for mesalamine and Local Neoplasm Recurrence
Article | Year |
---|---|
Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Topics: Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control St | 2021 |
1 other study available for mesalamine and Local Neoplasm Recurrence
Article | Year |
---|---|
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Colitis, Ulcerat | 2022 |